Insulet
PODD
#1015
Rank
S$25.54 B
Marketcap
$364.13
Share price
3.40%
Change (1 day)
31.29%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2024 (TTM): S$0.44 Billion

According to Insulet's latest financial reports the company's current earnings are S$1.98 Billion. In 2023 the company made an earning of S$0.34 Billion, an increase over its 2022 earnings that were of S$59.09 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.44 B29.67%
2023 S$0.34 B481.9%
2022 S$59.09 M-45.24%
2021 S$0.10 B43.35%
2020 S$75.27 M18.51%
2019 S$63.51 M41.16%
2018 S$44.99 M-711.95%
2017 -S$7.36 Million-56.85%
2016 -S$17.05 Million-79.31%
2015 -S$82.39 Million63.85%
2014 -S$50.28 Million31.04%
2013 -S$38.37 Million-21.96%
2012 -S$49.17 Million
2010 -S$46.9 Million-42.38%
2009 -S$81.39 Million-33.56%
2008 -S$0.13 Billion65.93%
2007 -S$73.83 Million209.75%
2006 -S$23.84 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-S$5.29 Million-101.14%๐Ÿ‡บ๐Ÿ‡ธ USA
-S$0.18 Billion-136.81%๐Ÿ‡บ๐Ÿ‡ธ USA
S$1.04 B 126.11%๐Ÿ‡บ๐Ÿ‡ธ USA
S$25.22 B 5,351.99%๐Ÿ‡บ๐Ÿ‡ธ USA
S$9.29 B 1,908.89%๐Ÿ‡บ๐Ÿ‡ธ USA
S$8.11 B 1,654.59%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
S$13.91 B 2,908.45%๐Ÿ‡บ๐Ÿ‡ธ USA